<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Factors Influencing Treatment Post-Chemo in dMMR Endometrial Cancer

Bradley Corr, MD, discussed the use of immune checkpoint inhibitors in patients with advanced endometrial cancer. This is the second of 2 articles based on this event.

minute read

by Targeted Oncology | November 9, 2023
placeholder